{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T09:07:37Z","timestamp":1694682457477},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.transci.2007.06.002","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T10:23:53Z","timestamp":1193135033000},"page":"93-102","source":"Crossref","is-referenced-by-count":5,"title":["A single unit lymphoma experience \u2013 Outcome in a Cape Town academic centre"],"prefix":"10.1016","volume":"37","author":[{"given":"Lucille","family":"Wood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Gavine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Juritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2007.06.002_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/dc.2840010111","article-title":"Intraoperative cytology of lymph nodes and lymphoid lesions","volume":"1","author":"Wilkerson","year":"1985","journal-title":"Diagn Cytopathol"},{"issue":"Suppl. 1","key":"10.1016\/j.transci.2007.06.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0046-8177(89)90287-6","article-title":"Imprint cytology of non-Hodgkin\u2019s lymphoma based on a study of 212 immunologically characterized cases: correlation of touch imprints with tissue sections","volume":"20","author":"Koo","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.transci.2007.06.002_bib3","first-page":"180","article-title":"Fine needle aspiration cytology of non-Hodgkin\u2019s lymphomas: a morphologic and immunophenotypic study","volume":"39","author":"Daskalopoulou","year":"1995","journal-title":"Acta Cytol"},{"key":"10.1016\/j.transci.2007.06.002_bib4","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1200\/JCO.2004.02.104","article-title":"Utility of fine-needle aspiration as a diagnostic technique in lymphoma","volume":"22","author":"Hehn","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2007.06.002_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0037-1963(01)90045-9","article-title":"Flow cytometric analysis of lymphomas and lymphoproliferative disorders","volume":"38","author":"Stetler-Stevenson","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2007.06.002_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1521-6926(03)00068-9","article-title":"Flow cytometry in lymphoma diagnosis and prognosis: useful?","volume":"16","author":"Stetler-Stevenson","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.transci.2007.06.002_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5858\/1999-123-0068-PFTEOS","article-title":"Protocol for the examination of specimens from patients with non-Hodgkin\u2019s lymphoma: a basis for checklists. The Cancer Committee, College of American Pathologists","volume":"123","author":"Compton","year":"1999","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.transci.2007.06.002_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-0339(199911)21:5<305::AID-DC1>3.0.CO;2-6","article-title":"Hematopathologists and cytopathologists: enemies or allies?","volume":"21","author":"Young","year":"1999","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.transci.2007.06.002_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1097-0339(200006)22:6<336::AID-DC2>3.0.CO;2-2","article-title":"Diagnosis and classification of lymphoma based on cytospin preparations: a comparison of hematopathologists and cytopathologists","volume":"22","author":"Fang","year":"2000","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"10.1016\/j.transci.2007.06.002_bib10","first-page":"42","article-title":"Morphoimmunohistochemical differential diagnosis of B-cell lymphomas","volume":"68","author":"Kovrigina","year":"2006","journal-title":"Arkh Patol"},{"key":"10.1016\/j.transci.2007.06.002_bib11","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/1097-0142(19920315)69:6+<1600::AID-CNCR2820691316>3.0.CO;2-#","article-title":"Classification and staging of lymphoma by molecular genetics","volume":"69 Suppl","author":"Gulley","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2007.06.002_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/14737159.4.1.83","article-title":"Role of molecular studies in the classification of lymphoma","volume":"4","author":"Bagg","year":"2004","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.transci.2007.06.002_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00277-003-0649-6","article-title":"DNA microarrays analysis in malignant lymphomas","volume":"82","author":"Schaenen","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.transci.2007.06.002_bib14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.blre.2004.11.003","article-title":"Microarray-based gene expression profiling of hematologic malignancies: basic concepts and clinical applications","volume":"19","author":"Margalit","year":"2005","journal-title":"Blood Rev"},{"issue":"9","key":"10.1016\/j.transci.2007.06.002_bib15","first-page":"16","article-title":"Lymphoma: the immune system in disarray","volume":"4","author":"Jacobs","year":"2004","journal-title":"The Specialist Forum"},{"key":"10.1016\/j.transci.2007.06.002_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.transci.2004.10.001","article-title":"Lymphoma \u2013 the immune system in disarray. Theme for the 11th Congress of the South African Lymphoma Study Group meeting","volume":"32","author":"Jacobs","year":"2005","journal-title":"Transfus Apheresis Sci"},{"key":"10.1016\/j.transci.2007.06.002_bib17","series-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","year":"2001"},{"key":"10.1016\/j.transci.2007.06.002_bib18","first-page":"13","article-title":"A staging of lymphomas: practical thoughts on impratical practices","volume":"10","author":"Raubitschek","year":"1990","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.transci.2007.06.002_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/1042819021000040251","article-title":"Prognostic significance of 18F-fluorodeoxyglucose positron emission tomography in lymphoma","volume":"44","author":"Weihrauch","year":"2003","journal-title":"Leuk Lymph"},{"key":"10.1016\/j.transci.2007.06.002_bib20","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2002-09-2778","article-title":"Utility of FDG-PET scanning in lymphoma by WHO classification","volume":"101","author":"Elstrom","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.06.002_bib21","first-page":"111","article-title":"Bone marrow examination in clinical practice","volume":"9","author":"Bird","year":"1995","journal-title":"Hematol Rev"},{"key":"10.1016\/j.transci.2007.06.002_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/jcp.53.11.835","article-title":"Evaluation of B-cell lymphoid infiltrates in bone marrow biopsies by morphology, immunohistochemistry, and molecular analysis","volume":"53","author":"Maes","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.transci.2007.06.002_bib23","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/1097-0142(19850401)55:7<1501::AID-CNCR2820550714>3.0.CO;2-K","article-title":"Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin\u2019s disease, non-Hodgkin\u2019s lymphoma, and non-malignant lymphadenopathy","volume":"55","author":"Margerison","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2007.06.002_bib24","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.4065\/71.11.1089","article-title":"Clinical approach to the patient with abnormal liver test results","volume":"71","author":"Kamath","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.transci.2007.06.002_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1034\/j.1600-0609.2001.5790493.x","article-title":"Kidney involvement and renal manifestations in non-Hodgkin\u2019s lymphoma and lymphocytic leukemia: a retrospective study in 700 patients","volume":"67","author":"Da\u2019as","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.transci.2007.06.002_bib26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2141.1986.tb07517.x","article-title":"The clinical usefulness of C-reactive protein measurements","volume":"63","author":"Gozzard","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2007.06.002_bib27","first-page":"701","article-title":"The prognostic significance of \u03b22-microglobulin in patients with Hodgkin\u2019s lymphoma","volume":"87","author":"Vassilakopoulos","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2007.06.002_bib28","doi-asserted-by":"crossref","unstructured":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma. The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987\u2013994.","DOI":"10.1056\/NEJM199309303291402"},{"key":"10.1016\/j.transci.2007.06.002_bib29","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.1994.12.7.1343","article-title":"Applicability of the international index for aggressive lymphomas to patients with low-grade lymphoma","volume":"12","author":"Lopez-Guillermo","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2007.06.002_bib30","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood.V86.4.1460.bloodjournal8641460","article-title":"International prognostic index for aggressive non-hodgkin\u2019s lymphoma is valid for all malignancy grades","volume":"86","author":"Hermans","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.06.002_bib31","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1200\/JCO.2005.03.1674","article-title":"New treatment options have changed the survival of patients with follicular lymphoma","volume":"23","author":"Fisher","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2007.06.002_bib32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/asheducation-2006.1.295","article-title":"Optimal use of prognostic factors in non-Hodgkin lymphoma","author":"Sehn","year":"2006","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.transci.2007.06.002_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1008254617270","article-title":"Does surgery belong to medical history for gastric lymphomas?","volume":"8","author":"Coiffier","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2007.06.002_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/1024533021000059456","article-title":"Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma","volume":"8","author":"Aviles","year":"2003","journal-title":"Hematology"},{"key":"10.1016\/j.transci.2007.06.002_bib35","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.critrevonc.2003.04.002","article-title":"Complications of cytotoxic chemotherapy in older patients: focus on myelotoxicity in lymphomas","volume":"48 Suppl","author":"Zinzani","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.transci.2007.06.002_bib36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(03)15383-4","article-title":"Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review","volume":"363","author":"Peppercorn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2007.06.002_bib37","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S0959-8049(01)00446-4","article-title":"The achievements of the EORTC Lymphoma Group. The EORTC Lymphoma Group","volume":"38 Suppl","author":"Raemaekers","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.transci.2007.06.002_bib38","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1200\/JCO.1998.16.12.3810","article-title":"BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP\/ABVD in patients with advanced-stage Hodgkin\u2019s lymphoma: interim report from a trial of the German Hodgkin\u2019s Lymphoma Study Group","volume":"16","author":"Diehl","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2007.06.002_bib39","unstructured":"Registration of clinical trials: a step forward but still a long path ahead. Haematologica 2006;91:295\u2013296."},{"key":"10.1016\/j.transci.2007.06.002_bib40","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1200\/JCO.2003.07.022","article-title":"Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the eastern cooperative oncology group","volume":"21","author":"Coyne","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2007.06.002_bib41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/sj.bjc.6601560","article-title":"Potential health risks of complementary alternative medicines in cancer patients","volume":"90","author":"Werneke","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.transci.2007.06.002_bib42","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2007.06.002_bib43","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ctrv.2006.02.002","article-title":"The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning","volume":"32","author":"van Baardwijk","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.transci.2007.06.002_bib44","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.06.002_bib45","first-page":"1310","article-title":"Report of the committee on the staging of hodgkin\u2019s disease","volume":"26","author":"Rosenberg","year":"1966","journal-title":"Cancer Res"},{"key":"10.1016\/j.transci.2007.06.002_bib46","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.06.002_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/cyto.a.10051","article-title":"Optimization of three- and four-color multiparameter DNA analysis in lymphoma specimens","volume":"54","author":"Plander","year":"2003","journal-title":"Cytomet A"},{"key":"10.1016\/j.transci.2007.06.002_bib48","first-page":"168","article-title":"Current treatment and immunotherapy of Hodgkin\u2019s lymphoma","volume":"90","author":"Klimm","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2007.06.002_bib49","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood-2005-01-0173","article-title":"Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience","volume":"106","author":"Chadha","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.06.002_bib50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1097-0142(197108)28:2<306::AID-CNCR2820280208>3.0.CO;2-N","article-title":"Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma","volume":"28","author":"Luce","year":"1971","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2007.06.002_bib51","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2007.06.002_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3816\/CLM.2003.n.028","article-title":"Mood alterations in patients treated with chlorambucil","volume":"4","author":"Hehn","year":"2003","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.transci.2007.06.002_bib53","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1002\/1097-0142(19851215)56:12<2874::AID-CNCR2820561227>3.0.CO;2-2","article-title":"Reevaluation of prognostic significance of symptoms in Hodgkin\u2019s disease","volume":"56","author":"Gobbi","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2007.06.002_bib54","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1 Suppl","key":"10.1016\/j.transci.2007.06.002_bib55","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1023\/A:1008317426152","article-title":"Treatment of Hodgkin\u2019s disease: results and current concepts of the German Hodgkin\u2019s Lymphoma Study Group","volume":"11","author":"Sieber","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1016\/j.transci.2007.06.002_bib56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/j.seminhematol.2006.07.007","article-title":"Treatment of diffuse large B-cell lymphomas","volume":"43","author":"Fisher","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2007.06.002_bib57","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.2004.06.088","article-title":"Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin\u2019s lymphoma: Eastern cooperative oncology group study 1484","volume":"22","author":"Horning","year":"2004","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.transci.2007.06.002_bib58","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S0959-8049(01)00446-4","article-title":"The achievements of the EORTC Lymphoma Group","volume":"38","author":"Raemaekers","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.transci.2007.06.002_bib59","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1182\/blood-2004-10-3920","article-title":"High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS","volume":"105","author":"Deconinck","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.transci.2007.06.002_bib60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00277-003-0655-8","article-title":"HOVON 47\/EORTC 20013: chlorambucil versus 2x2 Gy involved field radiotherapy in stage III\/IV previously untreated follicular lymphoma patients","volume":"82","author":"Haas","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1016\/j.transci.2007.06.002_bib61","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/cncr.21877","article-title":"Conditional survival of patients with diffuse large B-cell lymphoma","volume":"106","author":"Moller","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.transci.2007.06.002_bib62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.seminhematol.2006.07.003","article-title":"Dose-intesified treatment of advanced-stage diffuse large B-cell lymphomas. The German high-grade non-Hodgkin-lymphoma study group","volume":"43","author":"Held","year":"2006","journal-title":"Semin Hematol"},{"key":"10.1016\/j.transci.2007.06.002_bib63","first-page":"496","article-title":"Dose-dense R-CHOP-14 supported by pegfilgrastim in patients with diffuse large B-cell lymphoma: a phase II study of feasibility and toxicity","volume":"91","author":"Brusamolino","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2007.06.002_bib64","first-page":"104","article-title":"Current status and perspective of antibody therapy in follicular lymphoma","volume":"91","author":"Buske","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2007.06.002_bib65","first-page":"114","article-title":"Radioimmunotherapy and autologous stem cell transplantation for the treatment of B-cell lymphomas","volume":"91","author":"Cilley","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2007.06.002_bib66","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.beha.2006.06.002","article-title":"The immune system as a foundation for immunologic therapy and hematologic malignancies: a historical perspective","volume":"19","author":"Baron","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"10.1016\/j.transci.2007.06.002_bib67","first-page":"34","article-title":"Immunohaematopoietic stem cell transplantation in South Africa \u2013 the first 40 years: an experimental and clinical model for approaching restorative medicine","volume":"6","author":"Jacobs","year":"2006","journal-title":"The Specialist Forum"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050207001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050207001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T02:32:53Z","timestamp":1629945173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050207001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1473050207001036"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2007.06.002","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}